Gefzuris

gefapixant · Merck Sharp & Dohme B.V.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Gefzuris, covering 2023-11-08 to 2023-11-08. Get the full timeline:

Most recent: EMA Application withdrawn: Gefzuris (gefapixant) — Merck Sharp & Dohme B.V.